GC Wealth Management RIA LLC lowered its position in shares of Relx Plc (NYSE:RELX – Free Report) by 14.2% during the fourth quarter, Holdings Channel reports. The fund owned 11,557 shares of the technology company’s stock after selling 1,912 shares during the quarter. GC Wealth Management RIA LLC’s holdings in Relx were worth $525,000 at the end of the most recent quarter.
A number of other hedge funds have also recently bought and sold shares of RELX. CENTRAL TRUST Co boosted its position in Relx by 1,290.2% during the fourth quarter. CENTRAL TRUST Co now owns 570 shares of the technology company’s stock worth $26,000 after acquiring an additional 529 shares during the last quarter. Versant Capital Management Inc purchased a new position in Relx during the fourth quarter worth approximately $31,000. Sierra Ocean LLC purchased a new position in Relx during the fourth quarter worth approximately $43,000. Private Trust Co. NA raised its stake in Relx by 119.9% during the third quarter. Private Trust Co. NA now owns 1,038 shares of the technology company’s stock worth $49,000 after purchasing an additional 566 shares during the period. Finally, Whipplewood Advisors LLC purchased a new position in Relx during the fourth quarter worth approximately $74,000. Institutional investors and hedge funds own 15.02% of the company’s stock.
Relx Stock Performance
Shares of RELX stock opened at $47.25 on Wednesday. The company’s fifty day simple moving average is $48.69 and its 200-day simple moving average is $47.57. Relx Plc has a 52 week low of $40.25 and a 52 week high of $51.99. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46. The company has a market cap of $87.82 billion, a PE ratio of 25.41, a P/E/G ratio of 2.73 and a beta of 0.90.
Relx Increases Dividend
Analyst Ratings Changes
A number of research firms have weighed in on RELX. Redburn Atlantic began coverage on shares of Relx in a research note on Wednesday, January 8th. They set a “buy” rating on the stock. StockNews.com downgraded shares of Relx from a “buy” rating to a “hold” rating in a research note on Tuesday, March 4th.
Check Out Our Latest Stock Analysis on RELX
About Relx
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Read More
- Five stocks we like better than Relx
- Insider Trading – What You Need to Know
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- How to invest in marijuana stocks in 7 steps
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- What Investors Need to Know to Beat the Market
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX – Free Report).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.